HPV Vaccination and the Risk of Invasive Cervical Cancer
Top Cited Papers
- 1 October 2020
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 383 (14), 1340-1348
- https://doi.org/10.1056/nejmoa1917338
Abstract
The efficacy and effectiveness of the quadrivalent human papillomavirus (HPV) vaccine in preventing high-grade cervical lesions have been shown. However, data to inform the relationship between quadrivalent HPV vaccination and the subsequent risk of invasive cervical cancer are lacking.Funding Information
- Stiftelsen för Strategisk Forskning (KF10-0046)
- Cancerfonden (CAN 2016/840)
- Vetenskapsrådet (2017-02346)
- China Scholarship Council (201507930001)
This publication has 33 references indexed in Scilit:
- Human papillomavirus and cervical cancerThe Lancet, 2013
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort StudyJNCI Journal of the National Cancer Institute, 2013
- Impact of an HPV6/11/16/18 L1 virus‐like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infectionInternational Journal of Cancer, 2011
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- The completeness of the Swedish Cancer Register – a sample survey for year 1998Acta Oncologica, 2009
- Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting InfectionJama-Journal Of The American Medical Association, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsThe New England Journal of Medicine, 2007
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control studyCancer Causes & Control, 2003